These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38900351)

  • 1. ASO Visual Abstract: Survival Outcomes for Patients with Esophageal Cancer and Post-Chemoradiotherapy Surgical T4b Disease: Is Palliative Resection Justified?
    Yang TY; Yeh CJ; Chiu CH; Chao YK
    Ann Surg Oncol; 2024 Jun; ():. PubMed ID: 38900351
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Survival Outcomes of Patients with Esophageal Cancer and Post-chemoradiotherapy Surgical T4b Disease: Is Palliative Resection Justified?
    Yang TY; Yeh CJ; Chiu CH; Chao YK
    Ann Surg Oncol; 2024 Jun; ():. PubMed ID: 38872044
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival Outcomes of Patients with Esophageal Cancer and Post-chemoradiotherapy Surgical T4b Disease: Is Palliative Resection Justified?
    Yang TY; Yeh CJ; Chiu CH; Chao YK
    Ann Surg Oncol; 2024 May; ():. PubMed ID: 38780688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Definitive Chemoradiotherapy for Stage IVa (T4b vs. N4) Esophageal Squamous Cell Carcinoma Based on the Japanese Classification System: A Retrospective Single-Center Study.
    Wada Y; Anbai A; Takagi N; Kumagai S; Okuyama E; Nanjo H; Sato Y; Motoyama S; Hashimoto M
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33375169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer.
    Ueda H; Takeda M; Ueda S; Kawakami H; Okuno T; Takegawa N; Hayashi H; Tsurutani J; Tamura T; Ishikawa K; Nishimura Y; Nakagawa K
    Oncotarget; 2017 Oct; 8(46):80286-80294. PubMed ID: 29113302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) for T4b Esophageal Cancer After Definitive Chemoradiotherapy.
    Defize IL; van der Horst S; Bülbul M; Haj Mohammad N; Mook S; Meijer GJ; Brosens LAA; Ruurda JP; van Hillegersberg R
    Ann Surg Oncol; 2021 May; 28(5):2730-2738. PubMed ID: 33341917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of esophageal fistula on patients with clinical T4b esophageal squamous cell carcinoma who received chemoradiotherapy: A retrospective analysis.
    Chen B; Deng M; Yang C; Dragomir MP; Zhao L; Bai K; Xi M; Hu Y; Zhu Y; Li Q
    Radiother Oncol; 2021 May; 158():191-199. PubMed ID: 33667583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival Impact of Surgical Resection in Locally Advanced T4b Oral Squamous Cell Carcinoma.
    Gangopadhyay A; Bhatt S; Nandy K; Rai S; Rathod P; Puj KS
    Laryngoscope; 2021 Jul; 131(7):E2266-E2274. PubMed ID: 33459389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Surgical Treatment in Very Advanced (T4b) Oral Cavity Squamous Cell Carcinomas.
    Patel EJ; Oliver JR; Vaezi A; Li Z; Persky M; Tam M; Hu KS; Jacobson AS; Givi B
    Otolaryngol Head Neck Surg; 2021 Sep; 165(3):431-437. PubMed ID: 33400630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Including Surgical Resection in the Multimodal Management of Very Locally Advanced Sinonasal Cancer.
    Karp JM; Hu KS; Persky M; Persky M; Jacobson A; Tran T; Li Z; Givi B; Tam MM
    Otolaryngol Head Neck Surg; 2022 Sep; 167(3):494-500. PubMed ID: 34962843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects and limitations of chemoradiotherapy in advanced lower rectal cancer focusing on T4b.
    Ozaki K; Kawai K; Nozawa H; Sasaki K; Murono K; Emoto S; Iida Y; Ishii H; Yokoyama Y; Anzai H; Sonoda H; Sugihara K; Ishihara S
    Int J Colorectal Dis; 2021 Jul; 36(7):1525-1534. PubMed ID: 33937942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant Superselective Intra-Arterial Cisplatin Chemoradiotherapy Combined With Surgery in Patients With T4 Squamous Cell Carcinoma of the Maxillary Sinus.
    Ikeda M; Suzuki M; Matsuzuka T; Ishii S; Sato H; Murono S
    J Oral Maxillofac Surg; 2022 Aug; 80(8):1445-1450. PubMed ID: 35636468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter Randomized Phase 2 Trial Comparing Chemoradiotherapy and Docetaxel Plus 5-Fluorouracil and Cisplatin Chemotherapy as Initial Induction Therapy for Subsequent Conversion Surgery in Patients With Clinical T4b Esophageal Cancer: Short-term Results.
    Sugimura K; Miyata H; Tanaka K; Makino T; Takeno A; Shiraishi O; Motoori M; Yamasaki M; Kimura Y; Hirao M; Fujitani K; Yasuda T; Mori M; Eguchi H; Yano M; Doki Y
    Ann Surg; 2021 Dec; 274(6):e465-e472. PubMed ID: 33065643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoradiotherapy versus triplet chemotherapy as initial therapy for T4b esophageal cancer: survival results from a multicenter randomized Phase 2 trial.
    Yamasaki M; Miyata H; Yamashita K; Hamakawa T; Tanaka K; Sugimura K; Makino T; Takeno A; Shiraishi O; Motoori M; Kimura Y; Hirao M; Fujitani K; Yasuda T; Yano M; Eguchi H; Doki Y
    Br J Cancer; 2023 Jul; 129(1):54-60. PubMed ID: 37142731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.
    Kawakami T; Tsushima T; Omae K; Ogawa H; Shirasu H; Kito Y; Yoshida Y; Hamauchi S; Todaka A; Machida N; Yokota T; Yamazaki K; Fukutomi A; Onozawa Y; Yasui H
    BMC Cancer; 2018 May; 18(1):573. PubMed ID: 29776344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of failure and implications for clinical target volume definition of locally advanced T4b rectal cancer identified with magnetic resonance imaging and treated using neoadjuvant chemoradiotherapy and surgery.
    Zhang YZ; Song M; Geng JH; Zhu XG; Li S; Li YH; Cai Y; Wang WH
    Radiother Oncol; 2021 Aug; 161():132-139. PubMed ID: 34126137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of MRI on the post-therapeutic diagnosis of T4 esophageal cancer.
    Harino T; Yamasaki M; Murai S; Yamashita K; Tanaka K; Makino T; Saito T; Yamamoto K; Takahashi T; Kurokawa Y; Nakajima K; Tomiyama N; Eguchi H; Nakamura H; Doki Y
    Esophagus; 2023 Oct; 20(4):740-748. PubMed ID: 37233847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
    Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction chemoradiotherapy including docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal cancer.
    Hashimoto M; Shirakawa Y; Maeda N; Tanabe S; Noma K; Sakurama K; Katsui K; Nishizaki M; Fujiwara T
    Esophagus; 2020 Apr; 17(2):127-134. PubMed ID: 31897761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic determinants of locally advanced buccal mucosa cancer: Do we need to relook the current staging criteria?
    Pillai V; Yadav V; Kekatpure V; Trivedi N; Chandrashekar NH; Shetty V; Rangappa V; Subramaniam N; Bhat V; Raghavan N; Kolur T; George N; Thomas T; Kuriakose MA
    Oral Oncol; 2019 Aug; 95():43-51. PubMed ID: 31345393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.